Senores Pharmaceuticals Appoints New Senior Management, Announces Resignation
Senores Pharmaceuticals Limited announced changes to its senior management on Tuesday, March 17, 2026. The company’s Board of Directors approved the appointment of Mr. Jatin Gajjar as a Senior Management Personnel (SMP) and Chief Technology Officer. Mr. Gajjar brings over three decades of leadership experience in pharmaceutical technology, manufacturing operations, and product development.Simultaneously, the company announced that Mr. Manohar Lalge, President - Research and Development, has resigned, effective March 17, 2026. He is also stepping down as an SMP of the company.According to a company statement, Mr. Gajjar’s expertise lies in complex...